Slosman Marvin
CEO and President
Slosman Marvin has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 13, 2026.
On the most recent filing, Slosman Marvin is listed as CEO and President at InspireMD, Inc. Inside the rolling window, Slosman Marvin reported 1 open-market purchase totaling $25K in NSPR and no open-market sales.
Companies traded
Other insiders at NSPR
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Slosman Marvin made?
Slosman Marvin has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Slosman Marvin trade?
Slosman Marvin has filed SEC Form 4 disclosures for 1 company, including NSPR.
When was Slosman Marvin's most recent SEC Form 4 filing?
Slosman Marvin's most recent SEC Form 4 filing on Tracefour is dated May 13, 2026.
What is Slosman Marvin's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Slosman Marvin is listed as CEO and President.
What is Slosman Marvin's total buy and sell value in the current window?
Inside the rolling retention window, Slosman Marvin bought $25K and sold $0 based on SEC Form 4 filings.
What was Slosman Marvin's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 21,000 NSPR shares on 2026-05-12, worth $25K, per SEC Form 4 filings.